• Necrostatin-1 for RIP1 Kinase Assays

  2026-08-18

  Necrostatin-1 provides a practical pharmacological control for separating RIP1-dependent necroptosis from broader cell injury. This workflow connects necroptosis assays with bone, liver, and acute kidney injury research while emphasizing solvent control, timing, and orthogonal validation.

• WZ4003: NUAK1/2 Inhibitor Workflow

  2026-08-17

  WZ4003 is a practical NUAK1/2 inhibitor for connecting target engagement with measurable changes in MYPT1 phosphorylation, cell-cycle progression, migration, invasion, and tau pathology. This workflow guide shows how to build better-controlled cell and brain-slice experiments while separating pathway-specific effects from general toxicity.

• Necrostatin-1 for RIP1 Kinase Assays

  2026-08-17

  Build more interpretable necroptosis experiments with Necrostatin-1, a selective RIP1 kinase inhibitor for pathway-focused cell and tissue-injury studies. This guide also shows how to use it alongside, rather than confuse it with, ferroptosis workflows inspired by obesity-associated adipose stem cell research.

• S1P/S1PR3 Signaling After Intracerebral Hemorrhage

  2026-08-16

  The reference study identifies S1PR3 as a regulator of neuronal apoptosis after acute intracerebral hemorrhage and connects this response to TNF-α, PI3K/AKT signaling, and caspase-3 activation. Its combination of mouse and HT22-cell experiments supports S1PR3 inhibition as a mechanistic strategy for studying secondary brain injury, while also highlighting the context-dependent effects of S1P signaling.

• Gamithromycin: From Serum Signal to Strategy

  2026-08-15

  Gamithromycin, also known as ML-1709460, offers a powerful translational case study in how matrix effects, pulmonary distribution, and AUC24h/MIC can reshape antimicrobial decision-making. This evidence-led article connects ribosomal mechanism with serum-aware experimental design, veterinary respiratory applications, and practical development strategy.

• Fluconazole for Candida Biofilm Research

  2026-08-15

  Fluconazole (SKU B2094) supports mechanistic studies of ergosterol disruption, Candida biofilm tolerance, and antifungal drug resistance. This guide connects stock preparation and susceptibility testing with the PP2A–autophagy findings reported in a recent Candida albicans study.

• LL-37, KE-18, and KR-12 in Biofilm Control

  2026-08-14

  The reference study shows that truncating the human host-defense peptide LL-37 can preserve or improve selected antimicrobial activity, but biocidal potency does not predict antibiofilm performance. By comparing MIC, crystal violet, XTT, and bacterial surface-binding assays, the authors identify KE-18 as a promising biofilm-prevention peptide while demonstrating that prevention and inhibition are distinct phenotypes.

• PMSF for Preserving Native Protein Complexes

  2026-08-14

  Phenylmethanesulfonyl fluoride (PMSF) is more than a routine extraction additive: it is a strategic tool for preserving proteome and complex integrity before biochemical measurement. This guide connects PMSF selectivity with recombinant eIF3 purification, Western blot reliability, and assay interpretation.

• Netarsudil (AR-13324) in Reliable Cell Assays

  2026-08-13

  This scenario-driven guide explains how Netarsudil (AR-13324), SKU B7807, can improve the interpretation and handling of cell viability, proliferation, and cytotoxicity experiments. It connects ROCK biology, formulation compatibility, assay optimization, and siRNA-codelivery evidence to practical laboratory decisions.

• Aclacinomycin A and the Logic of Nucleolar Stress

  2026-08-13

  Aclacinomycin A, or Aclarubicin, can serve as more than a cytotoxicity reagent: it is a strategic probe for connecting dual topoisomerase inhibition with persistent ribosomal DNA damage, PML-nucleolar responses, and apoptosis. This perspective translates recent genome-stability findings into practical assay and translational research guidance.

• Merbromin Workflows for Fluorescence and Inhibition

  2026-08-12

  Merbromin is a versatile Mercury dibromofluorescein disodium salt for fluorescence-based binding analysis, pharmaceutical quantitation, and enzyme inhibition workflows. Its combination of static fluorescence quenching, visible absorbance, and resonance Rayleigh scattering enables low-solvent assays with orthogonal readouts.

• How Translatome Remodeling Links Fasting and Tumors

  2026-08-12

  Yang et al. show that fasting suppresses global translation while selectively increasing translation of liver mRNAs required for lipid catabolism and ketogenesis. The study identifies a fatty acid–AMPK–MNK–eIF4E pathway that connects metabolic state to translational control and reveals a potential vulnerability in pancreatic tumors exposed to a ketogenic diet.

• Flavopiridol at the ER Stress–Stem Cell Interface

  2026-08-11

  Flavopiridol (L868275) offers a powerful way to separate CDK-driven proliferation effects from endoplasmic reticulum stress in intestinal stem cell studies. This article translates ER stress findings into a rigorous, cross-domain assay strategy for cancer research and regenerative biology.

• Gamithromycin Workflows for Veterinary Research

  2026-08-10

  Build more predictive veterinary antibiotic assays by pairing Gamithromycin exposure with serum-aware susceptibility testing and lung-focused pharmacokinetic readouts. This workflow connects bench MIC measurements to AUC24h/MIC interpretation while highlighting practical solvent, matrix, and translation controls.

• Necrostatin-1 Workflow for RIP1 Kinase Studies

  2026-08-09

  Build more reproducible necroptosis assays with Necrostatin-1, from compound handling and TNF-α challenge design to orthogonal cell-death readouts. The workflow also shows how RIP1 inhibition can help interpret host necrosis in infection and acute kidney injury (AKI) research without overcalling mechanism.

457 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page